Frontlight ResearchEarly access
Head and neck cancer trials in China
216 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
- Where
- Chengdu
- Age
- 18 years and over
- People
- 22
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07274852 - Phase 3Not yet taking people in ChinaDe-Escalation Surgery After Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 356
- Run by
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT07320690 - Phase 1Taking peopleA Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
- Where
- Chengdu
- Age
- 18 years and over
- People
- 16
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07232524 - No phaseTaking peopleClinical Treatments in Specialized Diseases of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC)
- Where
- Shanghai
- Age
- 18 years to 90 years
- People
- 1,000
- Run by
- Eye & ENT Hospital of Fudan University
See details and how to joinNCT04908696 - Phase 2Taking peopleA Study of YL202 in Selected Patients With Advanced Solid Tumors
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fushun, Fuzhou, Ganzhou, Guangzhou, Guilin, Hangzhou, Harbin, Hefei, Jinan, Jingzhou, Jinhua, Jining, Kunming, Linyi, Luoyang, Meizhou, Nanchang, Nanning, Nanyang, Qingdao, Shanghai, Shantou, Shenyang, Suzhou, Taiyuan, Taizhou, Ürümqi, Weifang, Wuhan, Xian, Xiangyang, Xinxiang, Xuzhou, Yueyang, Zhengzhou
- Age
- 18 years to 75 years
- People
- 200
- Run by
- MediLink Therapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT06107686 - Phase 1Taking peopleStudy of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 12
- Run by
- Therorna
See details and how to joinNCT07081984 - Phase 1Taking peopleA Study of GV20-0251 in Advanced or Refractory Solid Tumors
- Where
- Chengdu
- Age
- 18 years and over
- People
- 10
- Run by
- West China Hospital
See details and how to joinNCT07106827 - Phase 2Taking peopleA Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 186
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT06006169 - Phase 1Taking peopleA Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 21
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT06469008 - Phase 1Not yet taking people in ChinaEndostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Sichuan University
See details and how to joinNCT07154108 - Phase 2Not yet taking people in ChinaNeoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 24
- Run by
- Sun Yat-sen University
See details and how to joinNCT07145931 - No phaseTaking peopleA Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 35
- Run by
- Zhujiang Hospital
See details and how to joinNCT07133958 - Phase 2Taking peoplePembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
- Where
- Hangzhou, Ningbo, Qingdao, Tianjin, Wenzhou
- Age
- 18 years to 85 years
- People
- 80
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT05446467 - No phaseNot yet taking people in ChinaA Randomized Controlled Study on the Improvement of Medical Experience for Patients With Radiation-induced Oropharyngeal Mucositis Based on the RIS System of the Internet of Things
- Where
- Guangzhou, Huizhou, Jieyang, Meizhou
- Age
- 18 years to 65 years
- People
- 110
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07126457 - Phase 3Taking people2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma
- Where
- Changsha, Guangzhou, Guilin, Nanjing
- Age
- 18 years to 70 years
- People
- 422
- Run by
- Sun Yat-sen University
See details and how to joinNCT06492460 - No phaseTaking peopleNovel ROS-scavenging Nanoenzymes for the Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer
- Where
- Chengdu
- Age
- 18 years to 80 years
- People
- 30
- Run by
- West China Hospital
See details and how to joinNCT07064577 - Phase 1/2Taking peopleA Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma
- Where
- Shanghai
- Age
- 18 years and over
- People
- 68
- Run by
- Fudan University
See details and how to joinNCT07105592 - Phase 2Not yet taking people in ChinaPD-1 Inhibitor Therapy Versus Radiotherapy in MPR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy (HNC-SYSU-006)
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 50
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07090707 - Phase 2Not yet taking people in ChinaNeoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 50
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07079410 - Phase 2Taking peopleDalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCC
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 98
- Run by
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT06935188 - No phaseTaking peopleComparative Study of New Classification and Traditional Classification of Radioactive Oropharyngeal Mucositis
- Where
- Guangzhou, Huizhou, Jieyang, Meizhou
- Age
- 18 years and over
- People
- 264
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT06307327 - Phase 2Taking peopleSingle-Arm Exploratory Study of PD-L1 Antibody Plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Jinan
- Age
- 18 years to 85 years
- People
- 69
- Run by
- Xiuping Ding
See details and how to joinNCT07055841 - Phase 2Taking peoplePembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC
- Where
- Guangzhou
- Age
- 18 years to 70 years
- People
- 86
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT05272696 - Phase 2Taking peopleNeoadjuvant Low-Dose Radiotherapy Combined With Adebrelimab and Single-Agent Albumin-Bound Paclitaxel Chemotherapy for Early-Stage Oral Squamous Cell Carcinoma: A Prospective, Single-Arm Clinical Trial
- Where
- Wuhan
- Age
- 18 years to 70 years
- People
- 30
- Run by
- Jun Jia
See details and how to joinNCT07007364 - Phase 1/2Taking peopleA Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)
- Where
- Chengdu
- Age
- 18 years to 80 years
- People
- 58
- Run by
- West China Hospital
See details and how to joinNCT07035626